PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, featuring promising improvements throughout different clinical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, additional trustworthy option for therapeut